During a spontaneous breathing trial, which condition supports continuation of the trial?

During a spontaneous breathing trial, which condition supports continuation of the trial?

• A. Hemodynamic instability.
• B. Spontaneous breathing is not allowed.
• C. Stable oxygenation with FiO2 ≤0.5 and PEEP ≤8-10.
• D. Severe acid-base imbalance.

Answer: (C)

During a spontaneous breathing trial, the patient’s ability to breathe on their own while maintaining adequate oxygen delivery and stable perfusion is the key判断. The best signal to continue the trial is stable oxygenation achieved with minimal ventilator support, specifically FiO2 at or below 0.5 and PEEP at or below 8–10 cmH2O. This indicates the lungs can handle spontaneous breaths without needing high levels of support, suggesting readiness for possible extubation. If there’s hemodynamic instability, ongoing need for high FiO2 or high PEEP, or a severe acid–base disturbance, continuation would be unsafe because those conditions reflect insufficient reserve to tolerate spontaneous breathing. Spontaneous breathing not being allowed contradicts the purpose of the trial, which is to assess tolerance to breathing without full ventilator support. So, stable oxygenation with FiO2 ≤ 0.5 and PEEP ≤ 8–10 cmH2O best supports continuing the trial.

During a spontaneous breathing trial, the patient’s ability to breathe on their own while maintaining adequate oxygen delivery and stable perfusion is the key判断. The best signal to continue the trial is stable oxygenation achieved with minimal ventilator support, specifically FiO2 at or below 0.5 and PEEP at or below 8–10 cmH2O. This indicates the lungs can handle spontaneous breaths without needing high levels of support, suggesting readiness for possible extubation.

If there’s hemodynamic instability, ongoing need for high FiO2 or high PEEP, or a severe acid–base disturbance, continuation would be unsafe because those conditions reflect insufficient reserve to tolerate spontaneous breathing. Spontaneous breathing not being allowed contradicts the purpose of the trial, which is to assess tolerance to breathing without full ventilator support.

So, stable oxygenation with FiO2 ≤ 0.5 and PEEP ≤ 8–10 cmH2O best supports continuing the trial.